The American Cancer Society cites new life-saving medicines as a major reason the US cancer death rate fell 33% between 1991 and 2023. By comparison, the UK’s cancer death rate has fallen just 19% since the early 1970s.
The Trump administration is experiencing some cognitive dissonance: The new president’s Justice Department is going to bat for former President Joe Biden and his signature legislative accomplishment.
Senior Justice officials say they’ll head to court to stick up for Biden’s Inflation Reduction Act and its price controls on prescription drugs.
Meanwhile, the White House’s top health-care policymakers warn that those very price controls will kill American patients, undermine our economy and ultimately increase government health-care spending.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
Trump is fighting Biden’s drug-price battle — but patients will pay the cost
Sally C. Pipes
The American Cancer Society cites new life-saving medicines as a major reason the US cancer death rate fell 33% between 1991 and 2023. By comparison, the UK’s cancer death rate has fallen just 19% since the early 1970s.
The Trump administration is experiencing some cognitive dissonance: The new president’s Justice Department is going to bat for former President Joe Biden and his signature legislative accomplishment.
Senior Justice officials say they’ll head to court to stick up for Biden’s Inflation Reduction Act and its price controls on prescription drugs.
Meanwhile, the White House’s top health-care policymakers warn that those very price controls will kill American patients, undermine our economy and ultimately increase government health-care spending.
Read the entire op-ed here.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.